3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain, Postoperative
3
Breast Neoplasms
3
Colorectal Neoplasms
2
Colonic Neoplasms
2
Chronic Pain
2
Squamous Cell Carcinoma of Head and Neck
1
Postoperative Hemorrhage
1
Pilonidal Sinus
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Cisplatin
18
Magnetic Resonance Spectroscopy
11
Specimen Handling
9
Radiotherapy, Intensity-Modulated
7
Radiotherapy
7
Radiation
7
Carboplatin
7
Platinum
5
Chemoradiotherapy
5
1,2-diaminocyclohexaneplatinum II citrate
5
Surgical Procedures, Operative
4
Paclitaxel
4
Docetaxel
4
Biopsy
4
pembrolizumab
3
Surveys and Questionnaires
3
toripalimab
2
aldesleukin
2
X-Rays
2
Taxes
2
Observation
2
Interviews as Topic
2
Immunohistochemistry
2
Cetuximab
2
Adoptive Transfer
2
sacituzumab govitecan
1
merphos
1
ipatasertib
1
human papillomavirus vaccine, TA
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Oropharyngeal Neoplasms
×
Lidocaine
×
Clear all
NCT06747390
2026-05-12
856397
Abramson Cancer Center at Penn Medicine
Phase 1
Recruiting
30 enrolled